Distress and sleep quality in young amphetamine-type stimulant users with an affective or psychotic illness

Jacob J Crouse; Rico S C Lee; Django White; Ahmed A Moustafa; Ian B Hickie; Daniel F Hermens

doi:10.1016/j.psychres.2018.02.033

Back

Distress and sleep quality in young amphetamine-type stimulant users with an affective or psychotic illness

Journal article

Open access

Peer reviewed

Distress and sleep quality in young amphetamine-type stimulant users with an affective or psychotic illness

Jacob J Crouse, Rico S C Lee, Django White, Ahmed A Moustafa, Ian B Hickie and Daniel F Hermens

Psychiatry Research, Vol.262, pp.254-261

2018

DOI: https://doi.org/10.1016/j.psychres.2018.02.033

Appears in Thompson Institute Research Collection

Files and links (2)

pdf

PDF - Author Accepted Version (Open Access)532.92 kBDownload View

Accepted VersionPDF - Author Accepted Version (Open Access)CC BY-NC-ND V4.0, Open Access

url

https://doi.org/10.1016/j.psychres.2018.02.033View

Published Version

Abstract

methamphetamine

MDMA

neurocognition

youth mental health

Other Collaborations

Thompson Institute Special Collection

UniSC Diversity Area - Life Stages

Misuse of amphetamine-type stimulant (ATS) drugs may disrupt key neurodevelopmental processes in young people and confer protracted neurocognitive and psychopathological harm. ATS users with a co-occurring psychiatric illness are typically excluded from research, reducing generalizability of findings. Accordingly, we conducted a cross-sectional examination of key clinical, sleep, socio-occupational and neurocognitive measures in current, past and never users of ATS drugs who were accessing a youth mental health service (headspace) for affective- or psychotic-spectrum illnesses. Contrary to hypotheses, groups did not differ in psychotic symptomology, socio-occupational functioning or neurocognitive performance. Current ATS users were however significantly more distressed and reported poorer subjective sleep quality and greater subjective sleep disturbances than never users, with a trend toward greater depressive symptomology in current users. Regression analyses revealed that depressive symptoms, daily ATS use and socio-occupational functioning predicted distress, and depressive symptoms and distress predicted subjective sleep quality. Our findings suggest that distress and poor sleep quality reflect a particular pathophysiology among ATS-using patients, which may negatively impact treatment engagement. Delineating the factors that disrupt social and neurobiological development in young people (such as substance use) warrants further investigation, including longitudinal study.

Details

Title: Distress and sleep quality in young amphetamine-type stimulant users with an affective or psychotic illness
Authors: Jacob J Crouse (Author) - University of Sydney
Rico S C Lee (Author) - University of Sydney
Django White (Author) - University of Sydney
Ahmed A Moustafa (Author) - Western Sydney University
Ian B Hickie (Author) - University of Sydney
Daniel F Hermens (Author) - University of the Sunshine Coast - Faculty of Arts, Business and Law
Publication details: Psychiatry Research, Vol.262, pp.254-261
Publisher: Elsevier Ireland Ltd.
Date published: 2018
DOI: 10.1016/j.psychres.2018.02.033
ISSN: 0165-1781
Organisation Unit: University of the Sunshine Coast, Queensland; Thompson Institute
Language: English
Record Identifier: 99451357202621
Output Type: Journal article

Metrics

131 File views/ downloads

609 Record Views

15 Times Cited - Web of Science

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Domestic collaboration
Web Of Science research areas: Psychiatry

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

Source: InCites